Evidence map›Paper›PMID 41688092›Full record

ArticleChemSusChem2026

An Integrated Engineering Approach to Intensify the Biocatalytic Metaraminol Synthesis.

Berit Rothkranz, Nina Klos, William Graf von Westarp, Doris Hahn, Thomas Classen, Laura Grabowski, Rocco Gentile, Jesko Kaiser, Stephan Schott-Verdugo, Holger Gohlke and 2 more

Abstract read
In one paragraph

Article in ChemSusChem, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed.

  1. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

12 authors.

Berit RothkranzInstitute of Bio- and Geosciences (IBG-1): Biotechnology, Forschungszentrum Jülich GmbH, Jülich, Germany.ORCID 0000-0001-9884-9085
Nina KlosInstitute of Bio- and Geosciences (IBG-1): Biotechnology, Forschungszentrum Jülich GmbH, Jülich, Germany.ORCID 0000-0001-6160-6549
William Graf von WestarpBioeconomy Science Center (BioSC), c/o Forschungszentrum Jülich GmbH, Jülich, Germany.ORCID 0000-0002-6137-8942
Doris HahnInstitute of Bio- and Geosciences (IBG-1): Biotechnology, Forschungszentrum Jülich GmbH, Jülich, Germany.ORCID 0000-0003-3990-646X
Thomas ClassenInstitute of Bio- and Geosciences (IBG-1): Biotechnology, Forschungszentrum Jülich GmbH, Jülich, Germany.ORCID 0000-0002-3259-964X
Laura GrabowskiInstitute of Bio- and Geosciences (IBG-1): Biotechnology, Forschungszentrum Jülich GmbH, Jülich, Germany.ORCID 0000-0002-1486-8017
Rocco GentileBioeconomy Science Center (BioSC), c/o Forschungszentrum Jülich GmbH, Jülich, Germany.ORCID 0009-0007-1391-4986
Jesko KaiserBioeconomy Science Center (BioSC), c/o Forschungszentrum Jülich GmbH, Jülich, Germany.ORCID 0000-0002-6429-0911
Stephan Schott-VerdugoBioeconomy Science Center (BioSC), c/o Forschungszentrum Jülich GmbH, Jülich, Germany.ORCID 0000-0003-0735-1404
Holger GohlkeBioeconomy Science Center (BioSC), c/o Forschungszentrum Jülich GmbH, Jülich, Germany.ORCID 0000-0001-8613-1447
Andreas JupkeBioeconomy Science Center (BioSC), c/o Forschungszentrum Jülich GmbH, Jülich, Germany.ORCID 0000-0001-6551-5695
Dörte RotherInstitute of Bio- and Geosciences (IBG-1): Biotechnology, Forschungszentrum Jülich GmbH, Jülich, Germany.ORCID 0000-0002-2339-4431

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Metaraminol is a chiral amino alcohol and plays an important role as a precursor molecule and active pharmaceutical ingredient in industry. Its enzymatic synthesis has been developed in recent years and can serve as an alternative to conventional synthesis routes that use toxic, fossil-based resources. Although the enzymatic two-step reaction toward metaraminol has been intensively investigated in the past, full conversion has never been reached in the amine transaminase-catalyzed step. In this study, we focus on identifying and overcoming the hurdles of the transamination step to reach higher metaraminol yields. Photometric and LC-MS analyses revealed side-product formation as a major drawback for the enzymatic metaraminol synthesis. Besides the oxidation of (R)-3-OH-PAC as well as its imine formation with isopropylamine, we demonstrate for the first time the adduct formation of the cofactor pyridoxal-5'-phosphate with metaraminol. Only by changing the amine transaminase formulation to purified enzyme and increasing the concentration by tenfold, >99% product yield with a metaraminol concentration of 75 mM was reached. Further, we successfully integrated the amine donor l-alanine by applying a continuous product extraction system as an alternative to isopropylamine. We believe that our findings and optimization strategies can also serve as a blueprint for other amine-based syntheses.

Indexed as

Amino AlcoholsBiocatalysisStereoisomerismTransaminasesAmino AlcoholsTransaminasesamine transaminasechiral amino alcoholcontinuous product extractionoxazolidinePictet–Spengler product

Identifiers

PMID41688092
PMCPMC12904732

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.